ClinicalTrials.gg
Sign In

Choledocholithiasis clinical trials

The registry lists 109 studies for Choledocholithiasis across more than 10 countries. 24 are recruiting or about to start. 75 of them are mainly about Choledocholithiasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30.

Get an email when these change. Save the Choledocholithiasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
58
Status unknown
21
Recruiting
18
Not yet recruiting
6
Active, not recruiting
3
Terminated
2

Phase

Phase 4
5
Phase 2
2
Phase 3
1
Early Phase 1
1

Where

China
16
United States
12
Egypt
11
Korea, Republic of
7
Taiwan
4
India
4

Who runs them

Asian Institute of Gastroenterology, India (5) · National Taiwan University Hospital (4) · Beijing Friendship Hospital (3) · First People's Hospital of Hangzhou (3) · Stanford University (3) · University of Southern California (3) · National Liver Institute, Egypt (3) · National University of Malaysia (2)

What is being tested here

Drugs under test in Choledocholithiasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Butylscopolammonium Bromide101
Ketamine001
Etomidate001
Midazolam001
Indocyanine Green001

Coming up

0phase 3 studies under way
7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Who these studies take

Of the 18 Choledocholithiasis studies recruiting now, 10 (56%) set no upper age limit and 1 (6%) stop at 75 or younger. 4 (22%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (6%) take healthy volunteers.

Recruiting studies that take each age, of 18
AgeWomenMen
104 (22%)4 (22%)
1815 (83%)15 (83%)
3016 (89%)16 (89%)
4016 (89%)16 (89%)
5016 (89%)16 (89%)
6516 (89%)16 (89%)
7518 (100%)18 (100%)
8514 (78%)14 (78%)

Across all 109 studies, recruiting or not: 13% stop at 75 or younger and 3% at 65; 16% take children; 0% are for women only and 0% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Choledocholithiasis studies take

Of 43 interventional studies with no phase under Choledocholithiasis, half reached primary completion within 21 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase21 mo12–36 · 43 studies—21 mo12–36 · 41 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 109. Browse all 109 → or search them.